Skip to nav Skip to content


September 26, 2018

 All Issues
 Read the last issue of IDSA News Read the next issue of IDSA News 
In Memoriam

Sydney Finegold, MD, FIDSA, Past President of IDSA, passed away on September 17 at age 97.

Read More
IDSA and HIVMA Members Keep Up Pressure on CMS to Delay Harmful E/M Payment Proposal

IDSA and HIVMA continue to urge members of Congress to ask the Centers for Medicare & Medicaid Services (CMS) to delay the implementation of the proposed E/M payment and documentation policies and to work with the medical community to develop an alternative that is more balanced and fair to both patients and providers.

Read More
Diversity, Inclusion & Equity Task Force Members Named

Among the recommendations of the Governance Task Force approved by the IDSA Board of Directors at its June meeting was the establishment of a Diversity, Inclusion and Equity (DI&E) Task Force.

Read More
Journal Club

In this feature, a panel of IDSA members identifies and critiques important new studies in the current literature that have a significant impact on the practice of infectious diseases medicine. 
Reviews in this issue: Saving SIRS? Discernment of Sepsis from Non-Infectious Syndromes in the ED, Current Epidemiology of Bacterial Infections in Young Infants, Cost and Length of Stay Savings with Molecular Testing for Tuberculosis among U.S. Inpatients

Read More
Congressional Funding Agreement Supports ID and HIV Programs

The House and Senate have announced an agreement on a final fiscal year 2019 Labor, Health and Human Services and Department of Defense appropriations bill.

Read More
IDSA to Participate in World AMR Congress

The fourth annual World Antimicrobial Resistance Congress will bring 150 speakers and 400 stakeholders to Washington, D.C., Oct. 25 and 26 to discuss critical challenges and opportunities to advance antibiotic and diagnostics development.

Read More
Commemorating 15 Years of PEPFAR, Examining Challenges that Remain

IDSA cosponsored a Congressional briefing commemorating 15 years of the President’s Emergency Plan for AIDS Relief (PEPFAR) and looking at the challenges that remain in achieving HIV epidemic control.

Read More
Updates from the CLSI Subcommittee on Susceptibility Testing

The Clinical Laboratory and Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing met in June. Amy Mathers, MD, D(ABMM), IDSA liaison for CLSI, provided the following clinically relevant updates from the meeting.

Read More
IDSA Advocates for Continued Patient Access to in vitro Diagnostics

IDSA has continued to be highly engaged in the ongoing policy discussions regarding regulation for laboratory developed tests (LDTs).

Read More
Playing JeoparIDy on Capitol Hill

Members of Congress play JeoparIDy at the Coalition for Health Funding Public Health Fair, which was held on Capitol Hill earlier this month.

Read More
Science Speaks

IDSA’s Science Speaks blog discussed the newest tuberculosis treatments in the United States, and the ramifications of global TB data.

Read More
IDSA & ID in the News

On a daily basis, IDSA spokespersons interview with media organizations across the country, providing facts, perspectives and important public health information about infectious diseases to the public.

Read More
ICYMI: What’s Hot on MyIDSA

Here’s a glance at the latest discussions happening on MyIDSA, IDSA’s members-only online community (login required):

Read More

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.